JW Holdings Corporation (KRX: 096760)

Market Cap	216.93B
Revenue (ttm)	925.73B
Net Income (ttm)	68.22B
Shares Out	72.07M
EPS (ttm)	949.26
PE Ratio	3.17
Forward PE	n/a
Dividend	105.00 (3.49%)
Ex-Dividend Date	Dec 27, 2024

Volume	33,741
Open	3,020.00
Previous Close	3,045.00
Day's Range	2,990.00 - 3,060.00
52-Week Range	2,650.00 - 3,905.00
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 6, 2025

About JW Holdings

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair care, beauty care, and other cosmetics products; infant care system, gynecological examining table, sterilizer equipment, diagnostic imaging equipment,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 136
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 096760

Financial Performance

In 2023, JW Holdings's revenue was 928.07 billion, an increase of 7.35% compared to the previous year's 864.54 billion. Earnings were 19.03 billion, a decrease of -14.11%.